While one study showed that suppressing METTL14 with siRNA impaired colony formation and invasion of TNBC cells [42], two recent clinical investigations indicated that low expression of METTL14 in breast cancer tissue is associated with shorter survival time of patients and is an independent unfavorable indicator for TNBC [32, 33]. Here, METTL14 is linked to breast cancer.